期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

RNA干扰靶基因的体内研究进展 被引量：2

原文传递
导出
摘要 RNA干扰技术是本世纪肿瘤治疗中的研究焦点之一。肿瘤发病机制复杂,涉及多个异常表达的基因,这些异常基因在肿瘤发生、发展过程中互相影响,但其因果关系目前尚不清楚,因此在肿瘤的RNA干扰治疗中,学者针对不同的靶基因进行了研究,并得到不同的结果。本文就目前用于肿瘤RNA干扰靶基因的体内研究现状和进展进行综述。
作者 倪晶 夏伟
机构地区 上海市第七人民医院核医学科
出处 《中华实用诊断与治疗杂志》 2012年第5期423-426,共4页 Journal of Chinese Practical Diagnosis and Therapy
基金 上海市普陀区科委卫生系统自主创新重点项目(PTKW10-B01)
关键词 肿瘤 RNA干扰 基因 治疗
分类号 R730.5 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Kim J, Kim S W, Kim W J. PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy[J]. Oligonucleotides, 2011,21 (2) : 101-107.
  • 2Paccione R J, Miyazaki H, Patel V, et al. Keratin down- regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility [J]. Mol Cancer Ther,2008,7(9):2894-2903.
  • 3Huang C, Jiang T, Zhu L, et al. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo[J]. Int J Oncol,2011,38(6) :1637-1644.
  • 4袁羡,王国玉,倪晶,张玉娜,叶蓓鸿.特异性hTERT-siRNA介导RNAi在Hela细胞中的实验研究[J].中华实用诊断与治疗杂志,2011,25(4):350-354. 被引量：8
  • 5Seth S, Matsui Y, Fosnaugh K, etal. RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer[J]. Mol Ther,2011,19(5) :928 935.
  • 6Xu C, Gui Q, Chen W, et al. Small interference RNA targeting tissue factor inhibits human lung adenoearcinoma growth in vitroand in vivo[J]. J Exp Clin Cancer Res,2011,30(1) :63-74.
  • 7Gong M, Lu Z, Fang G, et al. A small interfering RNA targeting osteopontin as gastric eaneer therapeuties[J]. Cancer Lett, 2008,272 ( 1 ) : 148-159.
  • 8Wang J S, Zheng C L, Wang Y J, etal. Gene silencing of beta- catenin by RNAi inhibits cell proliferation in human esophageal cancer cells in vitro and in nude miee[J]. Dis Esophagus,2009, 22(2) : 151-162.
  • 9Zhang X, Ge Y L, Tian R H. The knockdown of c-myc expression by RNAi inhibits cell proliferation in human colon cancer HT-29 cells in vitro and in vivo[J]. Cell Mol Biol Lett, 2009,14(2) : 305-318.
  • 10Du W, Wang L, Cao S, et al. EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer[J]. J Cancer Res Clin Oncol,2009,135(9) : 1277- 1285.

二级参考文献34

  • 1刘晓峰,陈必良,马晓东,马向东,王德堂.促红细胞生成素与卵巢癌细胞缺氧耐受的关系[J].第四军医大学学报,2005,26(9):789-791. 被引量：2
  • 2Fromowitz F B, Viola M V, Chao S, et al.ras p21 expression in the progression of breast cancer[J].Hum Pathol,1987,18(12):1268-1275.
  • 3Jaquet K, Krause K, Tawakol-Khodai M, et al.Erythropoietin and VEGF exhibit equal angiogenic potential[J].Microvasc Res,2002,64(2):326-333.
  • 4Liu W M, Powles T, Shamash J, et al.Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity[J].Oncogene,2004,23(4):981-990.
  • 5Batra S, Perelman N, Luck L R, et al.Pediatric tumor cell express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival[J].Lab Invest,2003,83(10):1477-1487.
  • 6Hardee M E, Cao Y, Fu P, et al.Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression[J].PLoS One,2007,2(6): e549.
  • 7Kayser K, Gabius H J.Analysis of expression of erythropoietin binding sites in human lung carcinoma by the biotinylated liganed[J].Zentralhl Pathol,1992,138(4):266-270.
  • 8Westenfelder C, Baranowski R L.Erythropoietin stimulates proliferation of human renal carcinoma cells[J].Kidney Int,2000,58(2):647-657.
  • 9Acs G, Zhang P J, Rebbeek T R, et al.Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma[J].Cancer,2002,95(5):969-981.
  • 10Sawyer S T, Katyani P.Association of JAK2and STAT5 with erythropoietin receptors[J].J Biol Chem,1996,271(50):32430-32437.

共引文献21

同被引文献39

  • 1宋晖,辛晓燕,肖锋,王德堂,韩星,郭会玲.RNA干扰技术阻抑survivin基因表达对子宫颈癌细胞放射和化疗敏感性的影响[J].中华妇产科杂志,2006,41(8):554-558. 被引量：7
  • 2Sima N, Wang W, Kong D, et al. RNA interference against HPV16E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and P53 [J]. Apoptosis,2008,13(2) :273-281.
  • 3Bousarghin L, Touze A, Gaud G, et al. Inhibition of cervical cancer cell growth by human papillomavirus virus like particles packaged with human papillomavirus oncoprotein short hairpin RNAs[J]. Mol Cancer Ther,2009,8(2):357-365.
  • 4Putral L N, Bywater M J, Gu W, et al. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin[J]. Mol Pharmacol, 2005,68(5) :1311-1319.
  • 5Kreis N N, Sanhaji M, Kramer A, et al. Restoration of the tumor suppressor p53 by down regulating cyclin B1 in human papillomavirus 16 /18 infected cancer cells[J]. Oncogene,2010, 29(41) :5591 -5603.
  • 6Van Trappen P O, Ryan A, Carroll M, et al. A model for coexpression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer[J]. Br J Cancer,2002,87(5):537-544.
  • 7刘福军,高国兰,涂开家,等.靶向MDR1基因的小分子干扰RNA抑制卵巢癌的生长和增加化疗疗效的动物体内研究[J].中国癌症研究,2009,21(4):318-324.
  • 8Wulff H, Castle NA. Therapeutic potential of KCa3.1 blockers: recent advances and promising trends [J]. Expert Rev Clin Pharmacol, 2010,3 (3) :385-396.
  • 9Wei AD, Gutman GA, Aldrich R, et al. International Union of Pharmacology. L II. Nomenclature and molecular relationships of calcium-actlvated potassium channels [J]. Pharmacol Rev, 2005,57 (4) : 463-472.
  • 10Begenisich T, Nakamoto T, Ovitt CE, et al. Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4[J]. J Biol Chem,2004,279(46) :47681-47687.

引证文献2

二级引证文献4

中华实用诊断与治疗杂志
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部